Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis

被引:1
作者
Ouoba, Serge [1 ,2 ]
Ouedraogo, Jean Claude Romaric Pingdwinde [3 ]
Lingani, Moussa [2 ]
Bunthen, E. [1 ,4 ]
Hussain, Md Razeen Ashraf [1 ]
Ko, Ko [1 ]
Nagashima, Shintaro [1 ]
Sugiyama, Aya [1 ]
Akita, Tomoyuki [1 ]
Tinto, Halidou [2 ]
Tanaka, Junko [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan
[2] Inst Rech Sci Sante IRSS, Unite Rech Clin Nanoro URCN, Nanoro, Burkina Faso
[3] Inst Rech Sci Sante IRSS, Dept Med & Pharmacopee Tradit, Pharm, Ouagadougou, Burkina Faso
[4] Minist Hlth, Payment Certificat Agcy PCA, Phnom Penh, Cambodia
关键词
Hepatitis C; Seroprevalence; Prevalence; Genotype; Systematic review; Burkina Faso; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; CAMILLE-MEDICAL-CENTER; PREGNANT-WOMEN; BLOOD-DONORS; HIV COINFECTION; GLOBAL PREVALENCE; BOBO-DIOULASSO; B-VIRUS; SEROPREVALENCE;
D O I
10.1186/s12879-021-06817-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Detailed characteristics of Hepatitis C virus (HCV) infection in Burkina Faso are scarce. The main aim of this study was to assess HCV seroprevalence in various settings and populations at risk in Burkina Faso between 1990 and 2020. Secondary objectives included the prevalence of HCV Ribonucleic acid (RNA) and the distribution of HCV genotypes. Methods A systematic database search, supplemented by a manual search, was conducted in PubMed, Web of Science, Scopus, and African Index Medicus. Studies reporting HCV seroprevalence data in low and high-risk populations in Burkina Faso were included, and a random-effects meta-analysis was applied. Risk of bias was assessed using the Joanna Briggs institute checklist. Results Low-risk populations were examined in 31 studies involving a total of 168,151 subjects, of whom 8330 were positive for HCV antibodies. Six studies included a total of 1484 high-risk persons, and 96 had antibodies to HCV. The pooled seroprevalence in low-risk populations was 3.72% (95% CI: 3.20-4.28) and 4.75% (95% CI: 1.79-8.94) in high-risk groups. A non-significant decreasing trend was observed over the study period. Seven studies tested HCV RNA in a total of 4759 individuals at low risk for HCV infection, and 81 were positive. The meta-analysis of HCV RNA yielded a pooled prevalence of 1.65% (95% CI: 0.74-2.89%) in low-risk populations, which is assumed to be indicative of HCV prevalence in the general population of Burkina Faso and suggests that about 301,174 people are active HCV carriers in the country. Genotypes 2 and 1 were the most frequent, with 60.3% and 25.0%, respectively. Conclusions HCV seroprevalence is intermediate in Burkina Faso and indicates the need to implement effective control strategies. There is a paucity of data at the national level and for rural and high-risk populations. General population screening and linkage to care are recommended, with special attention to rural and high-risk populations.
引用
收藏
页数:11
相关论文
共 56 条
  • [1] [Anonymous], 2008, SCI SANTE
  • [2] Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis
    Benova, Lenka
    Mohamoud, Yousra A.
    Calvert, Clara
    Abu-Raddad, Laith J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (06) : 765 - 773
  • [3] Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
    Blach, Sarah
    Zeuzem, Stefan
    Manns, Michael
    Altraif, Ibrahim
    Duberg, Ann-Sofi
    Muljono, David H.
    Waked, Imam
    Alavian, Seyed M.
    Lee, Mei-Hsuan
    Negro, Francesco
    Abaalkhail, Faisal
    Abdou, Ahmed
    Abdulla, Maheeba
    Abou Rached, Antoine
    Aho, Inka
    Akarca, Ulus
    Al Ghazzawi, Imad
    Al Kaabi, Saad
    Al Lawati, Faryal
    Al Namaani, Khalid
    Al Serkal, Youssif
    Al-Busafi, Said A.
    Al-Dabal, Layla
    Aleman, Soo
    Alghamdi, Abdullah S.
    Aljumah, Abdulrahman A.
    Al-Romaihi, Hamad E.
    Andersson, Monique I.
    Arendt, Vic
    Arkkila, Perttu
    Assiri, Abdullah M.
    Baatarkhuu, Oidov
    Bane, Abate
    Ben-Ari, Ziv
    Bergin, Colm
    Bessone, Fernando
    Bihl, Florian
    Bizri, Abdul R.
    Blachier, Martin
    Blasco, Antonio J.
    Mello, Carlos E. Brandao
    Bruggmann, Philip
    Brunton, Cheryl R.
    Calinas, Filipe
    Chan, Henry L. Y.
    Chaudhry, Asad
    Cheinquer, Hugo
    Chen, Chien-Jen
    Chien, Rong-Nan
    Choi, Moon Seok
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 161 - 176
  • [4] Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C
    Childs, Kate
    Davis, Christopher
    Cannon, Mary
    Montague, Sarah
    Filipe, Ana
    Tong, Lily
    Simmonds, Peter
    Smith, Donald
    Thomson, Emma C.
    Dusheiko, Geoff
    Agarwal, Kosh
    [J]. JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1099 - 1105
  • [5] Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso:: A comparative analysis
    Collenberg, E
    Ouedraogo, T
    Ganamé, J
    Fickenscher, H
    Kynast-Wolf, G
    Becher, H
    Kouyaté, B
    Kräusslich, HG
    Sangaré, L
    Tebit, DM
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (05) : 683 - 692
  • [6] Hepatitis B Virus Prevalence and Vaccination in Men Who Have Sex With Men in West Africa (CohMSM ANRS 12324-Expertise France)
    Dah, Ter Tiero Elias
    Couderc, Clotilde
    Coulibaly, Alou
    Kouame, Malan Jean-Baptiste
    Agboyibor, Mawuenyegan Kouamivi
    Traore, Issa
    Maradan, Gwenaelle
    Castro, Daniela Rojas
    Mensah, Ephrem
    Anoma, Camille
    Keita, Bintou Dembele
    Spire, Bruno
    Laurent, Christian
    Granouillac, Bruno
    Izard, Suzanne
    March, Laura
    Peeters, Martine
    Serrano, Laetitia
    Berenger, Cyril
    Bourrelly, Michel
    Coulaud, Pierre-Julien
    Mora, Marion
    Sagaon-Teyssier, Luis
    Bernier, Adeline
    Palvadeau, Pamela
    Camara, Drissa
    Cisse, Oumar
    Diallo, Fodie
    Diarra, Mahamadou
    Keita, Abdoul Aziz
    Maiga, Kader
    Ouologuem, Aly
    Traore, Fode
    Aka, Niamkey Thomas
    Yoro, Stephane-Alain Babo
    Coulibaly, Noufo Hamed
    Kotchi, Rachelle
    Kouabenan, Patrick
    Lokrou, Kpassou Julien
    N'Guessan, Frederic Dibi
    Coulibaly, Christian
    Ilboudo, Ousseni
    Ouedraogo, Joseph
    Ouedraogo, Mamadou
    Thio, Elisabeth
    Toure, Juste Rodrigue
    Traore, Abdoulazziz
    Traore, Issa
    Yougbare, Fiffou
    Agbomadji, Kouakou Kokouvi Selom
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [7] Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
    Degenhardt, Louisa
    Peacock, Amy
    Colledge, Samantha
    Leung, Janni
    Grebely, Jason
    Vickerman, Peter
    Stone, Jack
    Cunningham, Evan B.
    Trickey, Adam
    Dumchev, Kostyantyn
    Lynskey, Michael
    Griffiths, Paul
    Mattick, Richard P.
    Hickman, Matthew
    Larney, Sarah
    [J]. LANCET GLOBAL HEALTH, 2017, 5 (12): : E1192 - E1207
  • [8] World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination
    Diarra, Birama
    Ouattara, Abdoul Karim
    Djigma, Florencia Wendkuuni
    Compaore, Tegwinde Rebeca
    Obiri-Yeboah, Dorcas
    Traore, Lassina
    Soubeiga, Serge Theophile
    Bado, Prosper
    Yara, Justine
    Pietra, Virginio
    Ouedraogo, Paul
    Bougouma, Alain
    Sanogo, Rokia
    Simpore, Jacques
    [J]. HEPATITIS MONTHLY, 2017, 17 (06)
  • [9] Dicko M, 2000, B WORLD HEALTH ORGAN, V78, P163
  • [10] Prevalence of hepatitis C among HIV-1, HIV-2 and dually reactive patients: A multi-country cross-sectional survey in West Africa
    Ekouevi, Didier K.
    Coffie, Patrick A.
    Tchounga, Boris K.
    Poda, Armel
    Jaquet, Antoine
    Dabis, Francois
    Eholie, Serge P.
    [J]. JOURNAL OF PUBLIC HEALTH IN AFRICA, 2018, 9 (02) : 100 - 104